Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Samsung Medical Center
This study is a randomized, double-blind, placebo-controlled, non-inferiority clinical trial.
Age
0–0
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. gestational age of 30 weeks or less or birth weight of 1250 g or less
2. born in Samsung Medical Center
3. confirmed to have hemodynamically significant patent ductus arteriosus (PDA) during day of life (DOL) 5 to 14
4. Definition of hemodynamically significant PDA: ductal size ≥ 1.5 mm with left-to-right shunt (or bidirectional shunt with dominant left-to-right blood flow) on the initial echocardiography plus at least one of clinical criteria.
* Clinical criteria
* Respiratory signs, including tachypnea, chest retraction, increased respiratory support, unable to wean respiratory support
* Physical signs, including a murmur, hyperdynamic precordium or bounding pulses
* Blood pressure problems, including decreased mean or diastolic pressure or increased pulse pressure
* Signs of congestive heart failure, including cardiomegaly, hepatomegaly or pulmonary congestion
You may not be if
Mortality within the first 48 hours of life
Ductal size \< 1.5 mm on the initial echocardiography
Right-to-left shunt or bidirectional shunting with dominant right-to-left shunt through PDA
congenital anomaly
bilateral intraventricular hemorrhage of grade 4
contraindication of ibuprofen (bleeding diasthesis, platelet count 10,000/mm3 or less, serum creatinine 2.0 mg/dL or greater, necrotizing enterocolitis stage 2 or greater